AMA is moving from mandate to delivery.
Since becoming operational, the African Medicines Agency is steadily building a continental regulatory system that strengthens national authorities, protects patients, and supports access to quality medical products across Africa
Our priority is simple: protect patients, expand equitable access to quality medical products, and support local manufacturing; while maintaining the highest standards of safety and efficacy.
By strengthening continental safety monitoring, enabling reliance and joint regulatory work, and advancing digital regulatory systems, AMA is laying the foundations for trusted, efficient regulation across Africa.
The African Medicines Agency is a Specialized Agency of the African Union whose main objective is to enhance the capacity of State Parties and Regional Economic Communities, to regulate medical products in order to improve access to quality, safe and efficacious medical products on the continent. The Headquarters of AMA is at Kigali, Rwanda as per the host country agreement between the African Union and the Government of Rwanda.
Across the continent, governments, regulators, and partners are working with renewed urgency to strengthen oversight of medicines and health technologies. These milestones highlight the tangible impact of our collective efforts as of May 2026.
AU Member States have ratified the AMA treaty
African countries have achieved WHO Maturity Level 3
Medical products have been listed at the continental level
